Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes

A Cortellini, A Leonetti, A Catino, P Pizzutillo, B Ricciuti, A De Giglio, R Chiari, P Bordi, D Santini, R Giusti, M De Tursi, D Brocco, F Zoratto, F Rastelli, F Citarella, M Russano, M Filetti, P Marchetti, R Berardi, M TorniaiD Cortinovis, E Sala, C Maggioni, A Follador, M Macerelli, O Nigro, A Tuzi, D Iacono, M R Migliorino, G Banna, G Porzio, K Cannita, M G Ferrara, E Bria, D Galetta, C Ficorella, M Tiseo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes'. Together they form a unique fingerprint.

Medicine & Life Sciences